Compared to GC in the TCGA cohort (TCGA-GC), both AFPGC and TCGA-GC showed enrichment in the alterations of RTK/RAS/PI(3)K and p53/cell cycle signaling pathways, but in different patterns. This evidence concerns the gene TP53 and gastric cancer.